News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
547,653 Results
Type
Article (39909)
Company Profile (111)
Press Release (507633)
Section
Business (154670)
Career Advice (2429)
Deals (28090)
Drug Delivery (99)
Drug Development (73238)
Employer Resources (141)
FDA (13622)
Job Trends (12329)
News (274744)
Policy (27100)
Tag
Academia (2540)
Alliances (39090)
Alzheimer's disease (1328)
Approvals (13602)
Artificial intelligence (185)
Bankruptcy (308)
Best Places to Work (10077)
Breast cancer (211)
Cancer (1616)
Cardiovascular disease (134)
Career advice (2036)
CAR-T (115)
Cell therapy (331)
Clinical research (59113)
Collaboration (575)
Compensation (220)
COVID-19 (2458)
C-suite (168)
Data (1562)
Diabetes (201)
Diagnostics (5703)
Earnings (54891)
Employer resources (129)
Events (75646)
Executive appointments (561)
FDA (14450)
Funding (545)
Gene therapy (241)
GLP-1 (635)
Government (4090)
Healthcare (16117)
Infectious disease (2569)
Interviews (520)
IPO (12708)
Job creations (2653)
Job search strategy (1672)
Layoffs (402)
Legal (5770)
Lung cancer (254)
Manufacturing (199)
Medical device (10539)
Medtech (10543)
Mergers & acquisitions (15707)
Metabolic disorders (530)
Neuroscience (1751)
NextGen: Class of 2025 (5589)
Non-profit (3999)
Northern California (1781)
Obesity (285)
Opinion (201)
Parkinson's disease (114)
Patents (154)
People (51140)
Phase I (18232)
Phase II (26023)
Phase III (19791)
Pipeline (689)
Postmarket research (2317)
Preclinical (7415)
Radiopharmaceuticals (209)
Rare diseases (308)
Real estate (4223)
Regulatory (18865)
Research institute (2133)
Resumes & cover letters (357)
Southern California (1558)
Startups (2857)
United States (15437)
Vaccines (564)
Weight loss (203)
Date
Last 7 days (512)
Last 30 days (2163)
Last 365 days (30334)
2025 (3869)
2024 (31004)
2023 (34631)
2022 (45135)
2021 (48434)
2020 (46827)
2019 (39981)
2018 (30321)
2017 (27291)
2016 (25987)
2015 (30370)
2014 (22848)
2013 (18610)
2012 (19996)
2011 (20936)
2010 (18531)
Location
Africa (727)
Arizona (136)
Asia (33600)
Australia (7022)
California (4035)
Canada (1546)
China (350)
Colorado (187)
Connecticut (181)
Europe (74951)
Florida (612)
Georgia (133)
Illinois (394)
Indiana (234)
Japan (113)
Maryland (653)
Massachusetts (2847)
Michigan (176)
Minnesota (249)
New Jersey (1170)
New York (1154)
North Carolina (699)
Northern California (1781)
Ohio (143)
Pennsylvania (898)
South America (991)
Southern California (1558)
Texas (599)
Utah (133)
Washington State (403)
547,653 Results for "proclara biosciences formerly known as neurophage".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
January 27, 2025
·
6 min read
Business
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101
Ankyra Therapeutics and Jenga Biosciences are pleased to announce today an exclusive license agreement to develop and commercialize JEN-101 (formerly known as cANK-101).
March 26, 2024
·
4 min read
Press Releases
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
January 7, 2025
·
1 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Press Releases
Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium
February 10, 2025
·
6 min read
Proclara Biosciences
Proclara ceased operations in 2021.
Press Releases
VION Biosciences Acquires Enzymatic Assay Innovator BioAssay Systems
February 5, 2025
·
2 min read
Press Releases
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
January 30, 2025
·
1 min read
1 of 54,766
Next
